Hassan Salari
Director Ejecutivo en Posh Cosmeceuticals, Inc. .
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Weitao Wang | M | 39 | 7 años | |
Rick Doman | M | - |
EACOM Timber Corp.
EACOM Timber Corp. Forest ProductsNon-Energy Minerals EACOM Timber Corp. engages in the manufacture and distribution of lumber and wood-based products, and the management of forest resources. It offers stud grade lumber, dimension lumber, machine-stress rated lumber, specialty lumber and engineered woods. The company was founded by Hassan Salari on April 2, 1980 and is headquartered in Montreal, Canada. | 44 años |
Moira Ong | F | 49 | 14 años | |
Yossef Av-Gay | M | 62 |
University of British Columbia
| 30 años |
Daniel Pauly | M | - |
University of British Columbia
| 30 años |
Angus Livingstone | M | - |
University of British Columbia
| 36 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Christian Bezy | M | 68 | - | |
Francine Salari | F | 66 | 3 años | |
Jeremy Curnock-Cook | M | 74 |
EACOM Timber Corp.
EACOM Timber Corp. Forest ProductsNon-Energy Minerals EACOM Timber Corp. engages in the manufacture and distribution of lumber and wood-based products, and the management of forest resources. It offers stud grade lumber, dimension lumber, machine-stress rated lumber, specialty lumber and engineered woods. The company was founded by Hassan Salari on April 2, 1980 and is headquartered in Montreal, Canada. | 16 años |
Blair Law | M | - | - | |
Ian Mallmann | M | 63 |
University of British Columbia
| 11 años |
David Filer | M | 76 | 3 años | |
Audrey Lew | F | 59 |
Chemokine Therapeutics Corp.
Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | 7 años |
David A. Nordquist | M | - |
University of British Columbia
| 8 años |
Derek Hemmes | M | - |
University of British Columbia
| 10 años |
Sebastian Jaimungal | M | - |
University of British Columbia
| 5 años |
Monica Thornton-Trump | F | - |
University of British Columbia
| 7 años |
Teck Seng Low | M | 69 |
The University of Southampton
| 8 años |
Akio Tanaka | M | 54 |
University of British Columbia
| 6 años |
Richard Azani | M | 65 | 3 años | |
Li Zhu | F | - |
University of British Columbia
| 3 años |
R. Culter | M | 48 | - | |
Brett Kagetsu | M | 54 |
University of British Columbia
| 8 años |
Nick B. Drake | M | - |
University of British Columbia
| 10 años |
Timothy Lowinger | M | 60 |
University of British Columbia
| 8 años |
Terry Hamilton | M | 61 |
University of British Columbia
| 5 años |
Bin Huang | M | 65 | 4 años | |
Jonathan Bey | M | 54 |
University of British Columbia
| 5 años |
Steve Veitch | M | - |
University of British Columbia
| 5 años |
Trevor Robinson | M | - |
University of British Columbia
| 18 años |
Wei Jiong Zhang | M | 71 |
University of British Columbia
| 6 años |
Patric Ouellette | M | - |
University of British Columbia
| 5 años |
John Priatel | M | 58 |
University of British Columbia
| 11 años |
Salim Dhanji | M | 44 |
University of British Columbia
| 8 años |
David Bridge | M | - |
University of British Columbia
| 6 años |
Dong Xiao Qiu | M | 62 |
University of British Columbia
| 5 años |
Frank S. Moyle | M | - |
University of British Columbia
| 9 años |
Kong Lok Yip | M | 48 |
University of British Columbia
| 5 años |
Chun Ning Shih | M | 60 |
University of British Columbia
| 6 años |
Wale Bolorunduro | M | - |
University of British Columbia
| 4 años |
Dominique F. Borrelly | M | 63 | 4 años | |
Gregory Burnett | M | - |
University of British Columbia
| 6 años |
Harrison Cookenboo | M | 65 |
University of British Columbia
| 5 años |
Helge Seetzen | M | - |
University of British Columbia
| 11 años |
Michelle Robinson | F | 53 |
University of British Columbia
| 6 años |
Paul Thomas | M | 50 |
University of British Columbia
| 3 años |
Mark W. Chu | M | 57 |
University of British Columbia
| 8 años |
Sanjay Bhanot | M | - |
University of British Columbia
| 7 años |
Mary Garden | F | 65 |
University of British Columbia
| 6 años |
Lola Maksumova | M | - | - | |
Andre Marziali | M | - |
University of British Columbia
| 4 años |
Wendi V. Rodrigueza | M | 58 |
University of British Columbia
| 8 años |
Douglas Richardson | M | - |
University of British Columbia
| 6 años |
Kurt Loewen | M | 54 |
University of British Columbia
| 6 años |
Peeyush Varshney | M | 57 |
University of British Columbia
| 8 años |
Bashir Jaffer | M | 76 |
Chemokine Therapeutics Corp.
Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | 2 años |
Walter Korz | M | 63 |
Chemokine Therapeutics Corp.
Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | - |
Bill Hunter | M | 61 |
University of British Columbia
| 4 años |
Jacqueline Simpson | F | - |
University of British Columbia
| 11 años |
Robert E. Cohen | M | - |
University of British Columbia
| 11 años |
Roger Quick | M | - |
University of British Columbia
| 7 años |
Darrin Erickson | M | - |
University of British Columbia
| 5 años |
George Gorzynski | M | - |
University of British Columbia
| 4 años |
Cyndi Laval | F | - |
University of British Columbia
| 4 años |
Arie Page | F | 45 |
University of British Columbia
| 8 años |
Claire Huxtable | F | - |
University of British Columbia
| 6 años |
Shaun Foy | M | - |
University of British Columbia
| 9 años |
Brian Leeners | M | 58 |
University of British Columbia
| 7 años |
Jas Saini | M | 65 |
The University of Southampton
| 7 años |
Penny White | F | 52 | 1 años | |
Andrea Zaradic | F | 58 |
University of British Columbia
| 6 años |
William Edward Mufford | M | - |
University of British Columbia
| 6 años |
Ying Bin He | M | 62 |
University of British Columbia
| 5 años |
Kim Oishi | M | 60 |
University of British Columbia
| 7 años |
Mohammad Azab | M | 68 |
Chemokine Therapeutics Corp.
Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | 1 años |
Julien A. François | M | 46 |
University of British Columbia
| 4 años |
Rob Edel | M | - |
University of British Columbia
| 5 años |
Peter Smith | M | 55 |
University of British Columbia
| 3 años |
Peter Hnik | M | - |
University of British Columbia
| 1 años |
David Birch | M | - |
The University of Southampton
| 4 años |
Indira Samarasekera | M | 71 |
University of British Columbia
| 9 años |
John Osth | M | 77 |
Chemokine Therapeutics Corp.
Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | 4 años |
Matthias C. Kurth | M | 68 |
Chemokine Therapeutics Corp.
Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | 6 años |
David Smalley | M | 63 |
University of British Columbia
| 3 años |
Marin Katusa | M | 45 |
University of British Columbia
| 4 años |
C. Piazza | M | 77 |
Chemokine Therapeutics Corp.
Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | - |
Byron Berry | M | - |
University of British Columbia
| 4 años |
Brad Willock | M | - |
University of British Columbia
| 6 años |
Sean O'Reilly | M | - |
University of British Columbia
| 4 años |
Bill M. Gallacher | M | - |
University of British Columbia
| 4 años |
Martha C. Piper | M | 78 |
University of British Columbia
| 9 años |
Mike J. Dost | M | - |
University of British Columbia
| 2 años |
Stephen Kenwood | M | 62 |
University of British Columbia
| 4 años |
Yen You Zheng | M | 67 |
University of British Columbia
| 9 años |
Brandon Macdonald | M | - |
University of British Columbia
| 4 años |
Tim Termuende | M | 61 |
University of British Columbia
| 4 años |
Guy Ely | M | 71 |
Chemokine Therapeutics Corp.
Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | 1 años |
Mateusz Szeszkowski | M | 52 |
University of British Columbia
| - |
Donald Evans | M | 59 |
Chemokine Therapeutics Corp.
Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | - |
Robert King | M | 57 |
University of British Columbia
| 4 años |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Canadá | 93 | 93.00% |
Hong-Kong | 4 | 4.00% |
Reino Unido | 3 | 3.00% |
Iran | 0 | -.--% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Hassan Salari
- Red Personal